Role of Patient’s Age and Comorbidities in Therapy of Chronic Lymphocytic Leukemia
Background & Aims. New schemes of the antitumor therapy of CLL resulted in improvement of survival of relatively young patients. However, the therapy outcomes of elderly patients are still unsatisfactory. Erroneous overestimation of expected toxicity of standard therapeutic regimens in some elde...
Main Authors: | VV Strugov, EA Stadnik, YuV Virts, TO Silina, AYu Zaritskii |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Practical Medicine Publishing House
2016-04-01
|
Series: | Kliničeskaâ onkogematologiâ |
Subjects: | |
Online Access: | http://bloodjournal.ru/en/role-of-patient-s-age-and-comorbidities-in-therapy-of-chronic-lymphocytic-leukemia/ |
Similar Items
-
Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia
by: VV Strugov, et al.
Published: (2017-04-01) -
The Future of Chronic Lymphocytic Leukemia Treatment- Balancing Efficacy, Safety and Cost
by: Valentin Goede, et al.
Published: (2013-10-01) -
T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia
by: Elisavet Vlachonikola, et al.
Published: (2021-06-01) -
Ibrutinib in the Treatment of Relapsed Chronic Lymphocytic Leukemia
by: EA Stadnik, et al.
Published: (2018-01-01) -
Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia
by: P. Martijn Kolijn, et al.
Published: (2021-08-01)